A CROSS-SECTIONAL OBSERVATIONAL STUDY TO ASSESS THE PREVALENCE OF AMLAPITTA AMONG DIAGNOSED CASES OF MUKHADUSHIKA.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 260
- 试验地点
- 1
- 主要终点
- The percentage of Mukhadushika patients reporting Amlapitta symptoms
研究概览
简要总结
Modern treatment approaches primarily target external symptoms but often neglect underlying systemic factors such as digestion and metabolism, which Ayurveda identifies as pivotal in disease manifestation. Recent research emphasises the role of gastrointestinal dysfunction, unhealthy dietary habits (such as consuming spicy, oily, and fast food), and psychological stress in the form of the gut-skin axis as a direct link between digestive health and skin conditions. [22] In Ayurveda also,Amlapitta (acid dyspepsia), characterized by increased Pitta and impaired digestion, is implicated in exacerbating skin conditions through systemic toxicity (Ama) and Pitta imbalance, resulting in several skin presentations like Kandu (itching), Mandala and Kotha (elevated circular lesions similar to urticaria), Pidika (papule and pustules, which can occur over any part of the body). Despite the recognition of these internal factors in Ayurvedic texts, there is limited clinical research exploring the association between Amlapitta and Mukhadushika. This study is necessary to scientifically evaluate the association between Amlapitta and Mukhadushika. Such evidence may drive the need for integrative management protocols for acne, offering a holistic approach addressing both systemic and local factors for improved patient outcomes.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 45.00 Year(s)(—)
- 性别
- All
入选标准
- •1 Patients presenting with classical signs and symptoms of Mukhadushika 2 Patients in the age group of 18 to 45 years 3 Patients who provide written informed consent for participation in the study.
排除标准
- •1 Patients with a history of immunosuppressive therapy 2 Pregnant and lactating women.
结局指标
主要结局
The percentage of Mukhadushika patients reporting Amlapitta symptoms
时间窗: 12 months to 18 months
次要结局
- Spearman’s correlation coefficient of r = 0.40 (p = 0.01) between Amlapitta symptom severity and Mukhadushika severity.(12 months to 18 months)
研究者
Dr Rohit Kumar
All india Institue of Ayurveda
